Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02045Sodium nitrite--
BADD_D02053Sofosbuvir0.024331%
BADD_D02056Somatuline depot--
BADD_D02058Sorafenib0.016823%
BADD_D02060Sotalol0.002109%
BADD_D02061Sotalol hydrochloride--
BADD_D02062Sparfloxacin--
BADD_D02066Spironolactone--
BADD_D02068Stavudine--
BADD_D02069Stiripentol0.000187%
BADD_D02070Streptokinase--
BADD_D02071Streptomycin--
BADD_D02091Sulfamethoxazole--
BADD_D02096Sulfur hexafluoride--
BADD_D02097Sulindac--
BADD_D02098Sumatriptan0.000395%
BADD_D02099Sumatriptan succinate--
BADD_D02100Sunitinib0.031844%
BADD_D02101Sunitinib malate--
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02106Tadalafil--
BADD_D02107Tafamidis0.020188%
BADD_D02111Tamoxifen0.000238%
BADD_D02112Tamoxifen citrate--
BADD_D02113Tamsulosin0.000214%
BADD_D02114Tamsulosin hydrochloride--
BADD_D02116Tapentadol hydrochloride--
BADD_D02117Tarazosin--
BADD_D02123Technetium--
The 38th Page    First    Pre   38 39 40 41 42    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target